Insider Transactions Reported by 12 Insiders of Bellerophon Therapeutics, Inc.

Location
Warren, NJ

There are no Buy or Sell transactions made by insiders since 12 Mar 2025

Bellerophon Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Peter Fernandes Chief Executive Officer, Principal Financial and Accounting Officer $310,000 07 Jun 2023
Nicholas Laccona Financial Officer, (Pfo & Pao) $155,000 10 Feb 2023
Parag Suresh Shah VP of Business Operations $155,000 07 Jun 2023
Martin Dekker VP of Engineering & Manufacturing $155,000 07 Jun 2023
Bobae Kim VP Reg. Affairs & Quality $155,000 07 Jun 2023
PCM Ai Opportunities Fund 10%+ Owner $111,776 07 Jun 2023
Scott P. Bruder Director $45,282 07 Jun 2023
Mary Ann Cloyd Director $45,282 07 Jun 2023
Crispin Teufel Director $45,282 07 Jun 2023
Wang Theodore T. Director $45,282 07 Jun 2023
Naseem Amin Director $30,296 07 Jun 2023
Puissance Capital Management LP 10%+ Owner 13 Oct 2023

Recent Insider Transactions by Companies or Individuals for Bellerophon Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.